news, journals and articles from all over the world.
In our series, The ECS Community Adapts and Advances, Jeffrey “Jeff” Henderson opened up about what he and his colleagues are worrying about—and some tips to getting through this unprecedented period. Jeff is a PhD candidate in Physical/Analytical Chemistry under the supervision of Professors Jamie Noël and David Shoesmith at the University of Western Ontario (Western), Canada.
The drug discovery program is focused on the assessment of hundreds of drug candidates in the CDI labs, to find the most promising potential therapies.
Rush University Medical Center is recruiting participants for a nationwide trial of a COVID-19 vaccine developed by the University of Oxford in England and AstraZeneca, a multinational pharmaceutical company.
In ECS series, The ECS Community Adapts and Advances, Chris Beasley shares he is upbeat about the future while recognizing the challenges of the present. He is Marketing Manager in Electrochemistry at Gamry Instruments where he has worked for 10 years. Gamry Instruments designs and builds precision electrochemical instrumentation and accessories. Chris received his BS magna cum laude in Chemistry from Kutztown University in 2000.
Follow the ECS series, The ECS Community Adapts and Advances, here: https://www.electrochem.org/ecs-blog/tag/ecs-adapts-and-advances/
In ECS series, The ECS Community Adapts and Advances, Dr. Arumugam “Ram” Manthiram shares how he is in awe of his research team’s ability to remain creative and productive amidst to COVID-19 pandemic. He also urges the science community to be proactive in confronting the pandemic and climate change challenges threatening the global community.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu